XML 60 R50.htm IDEA: XBRL DOCUMENT v3.21.2
Revenue, Credit Concentrations and Geographic Information - Disaggregates of Net Product Revenues by Product (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Revenue from External Customer [Line Items]        
Revenue $ 408,742 $ 476,784 $ 1,396,465 $ 1,408,338
Vimizim | Marketed by Company        
Revenue from External Customer [Line Items]        
Revenue 136,744 147,891 466,697 401,789
Naglazyme | Marketed by Company        
Revenue from External Customer [Line Items]        
Revenue 71,172 76,323 297,321 271,585
Kuvan | Marketed by Company        
Revenue from External Customer [Line Items]        
Revenue 67,687 123,993 217,257 368,604
Palynziq | Marketed by Company        
Revenue from External Customer [Line Items]        
Revenue 60,729 46,092 173,702 121,354
Brineura | Marketed by Company        
Revenue from External Customer [Line Items]        
Revenue 32,984 25,455 90,641 75,223
Voxzogo | Marketed by Company        
Revenue from External Customer [Line Items]        
Revenue 144 0 144 0
Firdapse | Marketed by Company        
Revenue from External Customer [Line Items]        
Revenue 0 0 0 1,316
Brineura, Firdapse, Kuvan, Naglazyme, Palynziq, and Vimizim | Marketed by Company        
Revenue from External Customer [Line Items]        
Revenue 369,460 419,754 1,245,762 1,239,871
Aldurazyme | Marketed by Genzyme        
Revenue from External Customer [Line Items]        
Revenue 24,380 40,987 102,517 128,945
Total net product revenues        
Revenue from External Customer [Line Items]        
Revenue $ 393,840 $ 460,741 $ 1,348,279 $ 1,368,816